Related Experiment Video
Updated: Jun 14, 2026

03:47
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Central nervous system tuberculomas in 23 patients
Horea Man1, Pierre Sellier, Monique Boukobza
1Department of Internal Medicine A, Lariboisière Hospital, Paris, France. horea.man@lrb.aphp.fr
Scandinavian Journal of Infectious Diseases
|March 20, 2010
Summary
Central nervous system tuberculomas, a severe tuberculosis complication, primarily affect young individuals from high-prevalence countries. Standard treatment regimens show effectiveness in disease control.
Area of Science:
- Neurology
- Infectious Diseases
- Radiology
Background:
- Central nervous system tuberculomas are infrequent but serious manifestations of tuberculosis.
- Tuberculosis remains a significant global health challenge, particularly in endemic regions.
Purpose of the Study:
- To retrospectively analyze the clinical, biological, radiological, pathological, and therapeutic characteristics of central nervous system tuberculomas.
- To evaluate the effectiveness of current treatment protocols for these rare lesions.
Main Methods:
- Retrospective study of 23 patients diagnosed with central nervous system tuberculomas.
- Review of clinical data, laboratory results, imaging (MRI), pathological findings, and treatment outcomes.
Main Results:
- The majority of patients (22/23) originated from tuberculosis-endemic countries.
- Magnetic resonance imaging (MRI) and bacteriological specimens were crucial for diagnosis.
- A 12-month treatment regimen, comprising an initial 2-month intensive phase followed by a 10-month continuation phase, led to disease control in 16 patients, with 3 deaths.
Conclusions:
- Central nervous system tuberculomas predominantly affect young adults from high-risk regions.
- Diagnostic modalities like MRI and bacteriology are essential.
- The evaluated anti-tuberculous drug regimen supports the current recommendation of a 12-month treatment duration.
Related Concept Videos
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...